Literature DB >> 35904604

Breast cancer patient-reported outcomes on level 1 and level 2 oncoplastic procedures using BREAST-Q®.

C A Pinto1, B Peleteiro2,3,4, C S Pinto5, F Osório6,7, S Costa6,7, A Magalhães7, H Mora6,7, J Amaral7, D Gonçalves6,7, J L Fougo6,7.   

Abstract

PURPOSE: In breast cancer management not only mortality and surgical morbidity measurements are important but also patient satisfaction indexes. The authors evaluated the satisfaction and health-related quality of life (HRQOL) using the breast-conserving therapy (BCT) and breast reduction (BR) modules of BREAST-Q®.
METHODS: This is a cross-sectional study that analyzed breast cancer patients consecutively submitted to breast surgery between January 2011 and April 2018 using two modules of BREAST-Q®. 968 patients were contacted and 232 answers were gathered: 171 patients submitted to oncoplastic level 1 surgery answered the BCT module and 61 submitted to oncoplastic level 2 surgery answered the BR module. Clinical data were retrieved from patients' medical records.
RESULTS: Among the 232 questionnaires received, the median scores for psychosocial well-being, sexual well-being and (postoperative) satisfaction with breasts for BCT and BR modules were, respectively, 77.0 and 73.5 (p = 0.17); 62.0 and 53.0 (p = 0.14); 72.0 and 66.0 (p = 0.66). The median of adverse effects of radiation in the BCT module was 87.0. The median satisfaction with outcome in the BR module was 86.0. Both groups of patients revealed high scores of satisfaction with care. For the BCT patients, satisfaction with breasts strongly correlated with sexual well-being and was moderately correlated with psychosocial and physical well-being. For the BR patients, the satisfaction with outcome strongly correlated with satisfaction with medical team and moderately correlated with the remaining scales.
CONCLUSION: Both oncoplastic surgery levels yielded similar satisfaction outcomes when assessed using BCT and BR modules of BREAST-Q®.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  BREAST-Q®; Breast cancer; Breast-conserving therapy module; Health-related quality of life; Reduction/mastopexy module; Satisfaction

Year:  2022        PMID: 35904604     DOI: 10.1007/s00432-022-04228-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.322


  34 in total

1.  The role of oncoplastic breast reduction in the conservative management of breast cancer: Complications, survival, and quality of life.

Authors:  Benigno Acea-Nebril; Carmen Cereijo-Garea; Alejandra García-Novoa; Cristina Varela-Lamas; Sergio Builes-Ramírez; Alberto Bouzón-Alejandro; Joaquín Mosquera-Oses
Journal:  J Surg Oncol       Date:  2017-01-13       Impact factor: 3.454

2.  The BREAST-Q: further validation in independent clinical samples.

Authors:  Stefan J Cano; Anne F Klassen; Amie M Scott; Peter G Cordeiro; Andrea L Pusic
Journal:  Plast Reconstr Surg       Date:  2012-02       Impact factor: 4.730

3.  Patient Satisfaction Following Level II Oncoplastic Breast Surgery: A Comparison with Mastectomy Utililizing the Breast-Q Questionnaire will be published in Surgical Oncology.

Authors:  Amy Bazzarelli; Laura Baker; William Petrcich; Jing Zhang; Angel Arnaout
Journal:  Surg Oncol       Date:  2020-11-13       Impact factor: 3.279

4.  Breast conserving surgery versus mastectomy: overall and relative survival-a population based study by the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  Peer Christiansen; Stina Lyck Carstensen; Bent Ejlertsen; Niels Kroman; Birgitte Offersen; Anne Bodilsen; Maj-Britt Jensen
Journal:  Acta Oncol       Date:  2017-11-23       Impact factor: 4.089

Review 5.  Quality indicators in breast cancer care: An update from the EUSOMA working group.

Authors:  Laura Biganzoli; Lorenza Marotti; Christopher D Hart; Luigi Cataliotti; Bruno Cutuli; Thorsten Kühn; Robert E Mansel; Antonio Ponti; Philip Poortmans; Peter Regitnig; Jos A van der Hage; Yvonne Wengström; Marco Rosselli Del Turco
Journal:  Eur J Cancer       Date:  2017-09-28       Impact factor: 9.162

6.  Breast-Q 15 prospective study: oncoplastic breast reduction improve quality of live for women with macromastia.

Authors:  Benigno Acea-Nebril; Carmen Cereijo-Garea; Alejandra García-Novoa; Alberto Bouzon-Alejandro; Joaquin Mosquera-Oses
Journal:  Breast J       Date:  2020-04-14       Impact factor: 2.431

7.  Bilateral reduction mammoplasty in combination with lumpectomy for treatment of breast cancer in patients with macromastia.

Authors:  Eugene Chang; Nathalie Johnson; Bruce Webber; James Booth; Dina Rahhal; David Gannett; William Johnson; Daisy Franzini; Henry Zegzula
Journal:  Am J Surg       Date:  2004-05       Impact factor: 2.565

Review 8.  A closer look at the BREAST-Q(©).

Authors:  Stefan J Cano; Anne F Klassen; Amie M Scott; Andrea L Pusic
Journal:  Clin Plast Surg       Date:  2013-04       Impact factor: 2.017

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

10.  Use of the BREAST-Q™ Survey in the Prospective Evaluation of Reduction Mammaplasty Outcomes.

Authors:  Isaias Vieira Cabral; Edgard da Silva Garcia; Rebecca Neponucena Sobrinho; Natália Lana Larcher Pinto; Yara Juliano; Joel Veiga-Filho; Lydia Masako Ferreira; Daniela Francescato Veiga
Journal:  Aesthetic Plast Surg       Date:  2017-11-09       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.